Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from camellia
Reexamination Certificate
2005-09-30
2009-02-17
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from camellia
C424S760000, C514S456000, C514S732000, C514S738000
Reexamination Certificate
active
07491413
ABSTRACT:
Provided are compositions comprising a vanilloid and tea catechins in amounts and proportions which combat virus infections in a human or animal. The vanilloid can be provided in the form of a dried pepper preparation and the tea catechins can be provided in the form of a green tea extract (or concentrate). These active ingredients can be provided separately or in combination. The administration of a such nutritional or other composition, desirably oral administration (in an amount effect) results in reduced virus infection or ameliorated symptoms of virus infection in a human or an animal in need of such a composition.
REFERENCES:
patent: 5569673 (1996-10-01), Morré et al.
patent: 5605810 (1997-02-01), Morré et al.
patent: 5670520 (1997-09-01), Gelfand et al.
patent: 6410052 (2002-06-01), Morré et al.
patent: 6410061 (2002-06-01), Morré et al.
patent: 6428818 (2002-08-01), Morré et al.
patent: 6528489 (2003-03-01), Papathanassiu
patent: 6593371 (2003-07-01), Staggs
patent: 6652890 (2003-11-01), Morré et al.
patent: 6759064 (2004-07-01), Morre et al.
patent: 7192612 (2007-03-01), Morre et al.
patent: 2001/0051184 (2001-12-01), Heng
patent: 2003/0215462 (2003-11-01), Wacher et al.
patent: WO 95/26743 (1995-10-01), None
Evans, A. Viral Infections of Humans—Epidemiology and Control. 1989. Third Ed. Publisher: Plenum Medical Book Co., New York, NY, pp. 68, 564-565, 687-704, 713-721.
Morre et al. J. Pharm. Phamacol. 2003. vol. 55, No. 7, pp. 987-994, SCISEARCH Abstract enclosed.
Matsubara et al. Biochem. Biophys. Res. Commun. 2003. vol. 310, No. 3, pp. 715-719, DRUGU Abstract enclosed.
Yagiz et al. FASEB J. 2003. vol. 17, No. 4-5, Abstract No. 457.5, BIOSIS Abstract enclosed.
Abell et al. (Sep. 1993) “Sindbis Virus Membrane Fusion is Mediated by Reduction of Glycoprotein Disulfide Bridges at the Cell Surface,”J. Virol. 67:5496-5501.
Adelson et al. (1999) “Inhibition of Human Immunodeficiency Virus (HIV-1) Replication in SupT1 Cells Transduced with and HIV-1 LTR-Driven PKR cDNA Construct,”Eur. J. Biochem. 264:806-815.
Bardwell et al. (Sep. 1993) “The Bonds that Tie: Catalyzed Disulfide Bond Formation,”Cell74:769-771.
Battini et al. (Feb. 1995) “Receptor-Binding Domain of Murine Leukemia Virus Envelope Glycoproteins,”J. Virol. 69:713-719.
Brightman et al. (1992) “A Growth Factor- and Hormone-Stimulates NADH Oxidase from rat Liver Plasma Membrane,”Biochim. Biophys. Acta. 1105:109-117.
Bruno et al. (1992) “Stimulation of NADH Oxidase Activity from Rat Liver Plasma Membranes by Growth Factors and Hormones is Decreased or Absent with Hepatoma Plasma Membranes,”Biochem. J. 284:625-628.
Caterina et al. (1991) “The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway,”Ann. Rev. Neurosci. 24:487-517.
Chivers et al. (1996) “The CXXC Motif: Imperatives for the Formation of Native Disulfide Bonds in the Cell,”EMBO J. 15:2659-2667.
Dehahn et al. (1997) “NADH Oxidase Activity Present on Both External and Internal Surfaces of Soybean Plasma membranes,”Biochim. Biophys. Acta. 1328:99-108.
Freedman, R.B. (Jun. 1989) “Protein Disulfide Isomerase: Multiple Roles in the Modification of Nascent Secretory Proteins,”Cell57:1069-1072.
Kishi et al. (1999) “The Plasma Membrane NADH Oxidase of HeLa Cells has Hydroquinone Oxidase Activity,”Biochim. Biophys. Acta. 1412:66-77.
Madani et al. (Dec. 1998) “An Endogenous Inhibitor of Human Immunodeficiency Virus in Human Lymphocytes is Overcome by the Viral Vof Protein,”J. Virol. 72:10251-10255.
Mitscher et al. (1994) “Chemoprotection: A Review of the Potential Therapeutic Antioxidant Properties of Green Tea (Camellia sinensis) and Certain of its Constituents.”Med. Res. Rev. 17:327-365.
Mizuno, T. (1992) “Inhibitory Effect of Tannic Acid Sulfate and Related Sulfates on Infectivity, Cytopathic Effect, and Giant ell Formation of Human Immunodeficiency Virus,”Planta Medica5:535-539.
Morré et al. (2000) “Preferential Inhibition by (−)-Epigallaocatechin-3-Gallate of the Cell Surface NADH Oxidase and Growth of transformed Cells in Culture,”Biochem. Pharmacol. 60:937-946.
Morré, D.J. (1998) “NADH Oxidase: A Multifunction Ectoprotien of the Eukaryotic Cell Surface,” In:Plasma Membrane Redox Systems and Their Role in Biological Stress and Disease, Asard et al. Eds., Kluwar Academic Publishers, Dordrecht, The Netherlands, pp. 121-156.
Morré et al. (1997) “A Protein Disulfide-Thiol Interchange Activity of HeLa Plasma Membranes Inhibited by the Antitumor Sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl) Urea,”Biochim. Biophys. Acta1325:117-125.
Morré et al. (1998) “Effect of the Quassinoids Glaucarubolone and Simalikalactone D on Growth of Cells Permanently Infected with Feline and Human Immunodeficiency Viruses and on Viral Infections,”Life Sci. 62:231-219.
Morré et al. (1994) “Inhibition by Brefeldin A of NADH Oxidation Activity of Rat Liver Golgi Aparatus Accelerated by GDP,”FEBS Lett. 346:199-202.
Morré, D.J. (1994) “Hormone- and Growth Factor-Stimulated NADH Oxidase,”Biorg. Biomemb. 26:625-628.
Morré et al. (1995) “Mechanism of Killing HeLa Cells by the Antitumor Sulfonyluea, N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl) Urea (LY181984),”Protoplasma184:188-195.
Morré et al. (Mar. 1995) “Capsaicin Inhibits Preferentially the NADH Oxidase and Growth of Transformed Cells in Culture,”Proc. Nat. Acad. Sci. USA92:1831-1835.
Morré et al. (1995) “The Antitumor Sulfonylurea N-(4-methylphenylsulsonyl)-N′-(4-chlorophenyl) urea (Ly181984) Inhibits NADH Oxidase Activity of HeLa Plasma Membranes,”Biochim. Biophys. Acta. 1240:11-17.
Morré et al. (1996) “Capsaicin Inhibits Plasma Membrane NADH Oxidase Growth of Human and Mouse Melanoma Lines,”Eur. J. Can. 32A:1995-2003.
Morré et al. (1997) “Is the Drug-Responsive NADH Oxidase of the Cancer Cell Plasma Membrane a Molecular Target for Adriamycin,”J. Bioeng. Biomemb. 29:269-280.
Mukoyama et al. (1991) “Inhibition of Rotavirus and Enterovirus Infections by Tea Extracts,”Jpn. J. Med. Sci. Biol. 44:181-186.
Nakane et al. (1990) “Differential Inhibitory Effects of Some Catechin Derivatives on the Activities of Human Immunodeficiency Virus Reverse Transcriptase and Cellular Deoxyribonucleic and Ribonucleic Acid Polymerase,”Biochem. 29:2841-2845.
Nakayama et al. (Aug. 1993) “Inhibition of the Infectivity of Influenza Virus by Tea Polyphenols,”Antiviral Res. 21:289-299.
Paulik et al. (1999) “Drug-Antibody Conjugates with Anti-HIV Activity,”Biochem. Pharmacol. 58:1781-1790.
Ryser et al. (May 1994) “Inhibition of Human Immunodeficiency Virus Infection by Agents that Interfere with Thiol-Disulfide Interchange Upon Virus-Receptor Interaction,”Proc. Nat. Acad. Sci. USA—91:4559-4563.
Morre D. James
Morre Dorothy M.
Greenlee Winner and Sullivan P.C.
Purdue Research Foundation
Tate Christopher R.
LandOfFree
Compositions and methods for treating and preventing virus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating and preventing virus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating and preventing virus... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4056420